APPLIED GENETIC TECHNOLOGIES CORP Quarterly Nonoperating Income (Expense) in USD from Q1 2013 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Applied Genetic Technologies Corp quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2013 to Q3 2022.
  • Applied Genetic Technologies Corp Nonoperating Income (Expense) for the quarter ending September 30, 2022 was -$991K, a 49.5% decline year-over-year.
  • Applied Genetic Technologies Corp Nonoperating Income (Expense) for the twelve months ending September 30, 2022 was -$2.9M, a 62.6% decline year-over-year.
  • Applied Genetic Technologies Corp annual Nonoperating Income (Expense) for 2022 was -$2.58M, a 85.3% decline from 2021.
  • Applied Genetic Technologies Corp annual Nonoperating Income (Expense) for 2021 was -$1.39M, a 218% decline from 2020.
  • Applied Genetic Technologies Corp annual Nonoperating Income (Expense) for 2020 was $1.18M, a 51.9% decline from 2019.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 -$2.9M -$991K -$328K -49.5% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-21
Q2 2022 -$2.58M -$585K -$86K -17.2% Apr 1, 2022 Jun 30, 2022 10-K 2022-09-27
Q1 2022 -$2.49M -$658K -$341K -108% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-16
Q4 2021 -$2.15M -$669K -$363K -119% Oct 1, 2021 Dec 31, 2021 10-Q 2022-02-14
Q3 2021 -$1.79M -$663K -$395K -147% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-21
Q2 2021 -$1.39M -$499K -$616K -526% Apr 1, 2021 Jun 30, 2021 10-K 2022-09-27
Q1 2021 -$774K -$317K -$602K -211% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$172K -$306K -$640K -192% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-14
Q3 2020 $468K -$268K -$712K -160% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $1.18M $117K -$835K -87.7% Apr 1, 2020 Jun 30, 2020 10-K 2021-09-23
Q1 2020 $2.02M $285K -$227K -44.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 $2.24M $334K -$186K -35.8% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-11
Q3 2019 $2.43M $444K -$27K -5.73% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 $2.46M $952K +$632K +198% Apr 1, 2019 Jun 30, 2019 10-K 2020-09-18
Q1 2019 $1.82M $512K +$187K +57.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 $1.64M $520K +$259K +99.2% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-05
Q3 2018 $1.38M $471K +$201K +74.4% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $1.18M $320K +$114K +55.3% Apr 1, 2018 Jun 30, 2018 10-K 2019-09-26
Q1 2018 $1.06M $325K +$89K +37.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 $973K $261K +$34K +15% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-07
Q3 2017 $939K $270K +$34K +14.4% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $905K $206K -$35K -14.5% Apr 1, 2017 Jun 30, 2017 10-K 2018-09-11
Q1 2017 $940K $236K +$34K +16.8% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 $906K $227K +$52K +29.7% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-09
Q3 2016 $854K $236K +$146K +162% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $708K $241K +$172K +249% Apr 1, 2016 Jun 30, 2016 10-K 2018-09-11
Q1 2016 $536K $202K +$137K +211% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $399K $175K +$123K +237% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-08
Q3 2015 $276K $90K +$62K +221% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 $214K $69K +$165K Apr 1, 2015 Jun 30, 2015 10-K 2017-09-13
Q1 2015 $49K $65K +$393K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 -$344K $52K -$2.12M -97.6% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-08
Q3 2014 $1.77M $28K +$5.13M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 -$3.35M -$96K Apr 1, 2014 Jun 30, 2014 10-K/A 2017-09-08
Q1 2014 -$328K +$343K +51.1% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 $2.17M Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-11
Q3 2013 -$5.1M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q1 2013 -$671K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.